Skip to main content
Year archive

BioInvent International — 2011 filings

All 23 regulatory filings released by BioInvent International (BINV) in 2011, sourced directly from the official regulator.

23 Filings
2011 Period
2011 filings (23)
Filing Released Lang
Rekryteringen av patienter till fas IIb-studien med TB-402 slutförd snabbare än beräknat
Regulatory Filings
2011-12-16 Swedish
BI-505 uppvisar effekt mot cancer i djurmodell
Regulatory Filings
2011-12-12 Swedish
Data på BI-505 presenteras hos American Society of Hematology
Regulatory Filings
2011-12-02 Swedish
BioInvent arrangerar kapitalmarknadsdag i Stockholm
Investor Presentation
2011-11-08 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report 9M 2011
2011-10-13 Swedish
Inbjudan till BioInvent Kapitalmarknadsdag
Report Publication Announcement
2011-09-12 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-07-15 English
Earnings Release 2011
Earnings Release H1 2011
2011-07-14 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-07-01 English
Ändring av antalet aktier och röster i BioInvent International AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2011-06-30 Swedish
Villkoren för BioInvents emission nu uppfyllda
Capital/Financing Update
2011-06-08 Swedish
BioInvent genomför riktad nyemission om cirka 136 miljoner kronor
Share Issue/Capital Change
2011-06-01 Swedish
BioInvent offentliggör placering av nya aktier
Capital/Financing Update
2011-05-31 Swedish
BioInvent och ThromboGenics rapporterar att partnern Roche inlett fas Ib/II-studie av läkemedelskandidaten, TB-403
Regulatory Filings
2011-05-16 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Q1 2011
2011-04-14 Swedish
BioInvent rekryterar Sten Westerberg som IR-chef
Board/Management Information
2011-04-12 Swedish
Årsstämma i BioInvent International AB
AGM Information
2011-03-24 Swedish
Första patienten doserad i klinisk fas II-studie med BioInvents läkemedelskandidat BI-204 mot hjärt-kärlsjukdomar
Regulatory Filings
2011-03-14 Swedish
Annual Report 2010
Annual Report FY 2010
2011-03-03 Swedish
KALLELSE TILL ÅRSSTÄMMA I BIOINVENT INTERNATIONAL AB
AGM Information
2011-02-22 Swedish
Positiva resultat från fas II-studie av TB-402 publicerade i Journal of Thrombosis and Haemostasis
Earnings Release FY 2011
2011-02-11 Swedish
Earnings Release 2010
Earnings Release FY 2010
2011-02-10 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-01-21 English